arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive Leaguearthyper-971Research ArticleОБЗОРЫREVIEWSГипертензия и ее последствия: состояние проблемы в миреClaudeL.noemail@neicon.ru2005280420051128689Copyright © Claude L., 20052005Claude L.Claude L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/971ReferencesKearney P.M., Whelton M., Reynolds К. et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22 (1): 11-19.Kearney P.M., Whelton M., Reynolds К. et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22 (1): 11-19.Najjar I., Kotchen T.A. Trends in prevalence. an awareness. treatment, and control оf hypertension in the United States. 1988-2000. JAMA 2003:290 (2): 199-206.Najjar I., Kotchen T.A. Trends in prevalence. an awareness. treatment, and control оf hypertension in the United States. 1988-2000. JAMA 2003:290 (2): 199-206.Mackay J., Mensah G. The Atlas of Heart Disease and Stroke. World Health Organization 2004.Mackay J., Mensah G. The Atlas of Heart Disease and Stroke. World Health Organization 2004.Cartwright F. A short history of blood pressure measurement. Proc Roy Soc Med 1977;.70: 793-9.Cartwright F. A short history of blood pressure measurement. Proc Roy Soc Med 1977;.70: 793-9.Comroe J., Exploring the Heart. Discoveries in heart disease and high blood pressure. New York: WW Norton & Co.; 1983.Comroe J., Exploring the Heart. Discoveries in heart disease and high blood pressure. New York: WW Norton & Co.; 1983.Al-Said J. The prevalence of hypertension in Persian Gulf countries and its correlation with demographic and socio-economic factors. J Hypertens 2005:23(6): 1273-7.Al-Said J. The prevalence of hypertension in Persian Gulf countries and its correlation with demographic and socio-economic factors. J Hypertens 2005:23(6): 1273-7.Fodor J.G., Lietava J., Rieder A. et al. Work-site hypertension prevalence and control in three Central European Countries. J Hum Hypertens 2004: 18 (8): 581-5.Fodor J.G., Lietava J., Rieder A. et al. Work-site hypertension prevalence and control in three Central European Countries. J Hum Hypertens 2004: 18 (8): 581-5.Kijkova R., Skodova Z., Lanska V. et al. Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001. Czech Post-MQNICA Stydy. J Hum Hypertens 2004; 18 (8): 571-9.Kijkova R., Skodova Z., Lanska V. et al. Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001. Czech Post-MQNICA Stydy. J Hum Hypertens 2004; 18 (8): 571-9.Stein A.D., Stoyanovsky V., Mincheva V. et al. Prevalence, awareness, treatment and control of hypertension in a working Bulgarian population. Eur J Epidemiol 2000; 16 (3): 265-70.Stein A.D., Stoyanovsky V., Mincheva V. et al. Prevalence, awareness, treatment and control of hypertension in a working Bulgarian population. Eur J Epidemiol 2000; 16 (3): 265-70.Shalnora S., Deev A., Organov R. Prevalence of hypertension in the Russian population. Healthcar Dis Prev 2001; 2: 3-7 (Translated from Russian).Shalnora S., Deev A., Organov R. Prevalence of hypertension in the Russian population. Healthcar Dis Prev 2001; 2: 3-7 (Translated from Russian).Kearney P.M., Whelton M., Reynolds К. et al. Global burden of hypertension; analysis of worldwide data. Lancet 2005; 365 (9455); 217-23.Kearney P.M., Whelton M., Reynolds К. et al. Global burden of hypertension; analysis of worldwide data. Lancet 2005; 365 (9455); 217-23.Yasan R.S., Beiser A., Seshadri S. et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study JAMA 2002; 287 (8): 1003-10.Yasan R.S., Beiser A., Seshadri S. et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study JAMA 2002; 287 (8): 1003-10.Kannel W.B., Schwartz M.J., McNamara P.M. Blood pressure and risk of coronary heart disease: the Framingham study: Dis Chest 1969; 56 (1): 43-52.Kannel W.B., Schwartz M.J., McNamara P.M. Blood pressure and risk of coronary heart disease: the Framingham study: Dis Chest 1969; 56 (1): 43-52.Stamler J., Neaton J.D., Wentworth D.N. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989; 13 (5 Suppl.): 12-12.Stamler J., Neaton J.D., Wentworth D.N. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989; 13 (5 Suppl.): 12-12.Miura K., Daviglus M.L., Dyer A.R. et al. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart. Association Detection Project in Industry. Arch Intern Med 2001: 161 (12): 1501-8.Miura K., Daviglus M.L., Dyer A.R. et al. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart. Association Detection Project in Industry. Arch Intern Med 2001: 161 (12): 1501-8.Lewington S., Clarke R., Qizilhash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360 (9349): 1903-13.Lewington S., Clarke R., Qizilhash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360 (9349): 1903-13.Ezzati M., Hoorn S.V., Rodgers A. et al. Estimates of global and regional potential health gains front reducing multiple major risk factors. Lancet 2003: 362 (9380): 271-80.Ezzati M., Hoorn S.V., Rodgers A. et al. Estimates of global and regional potential health gains front reducing multiple major risk factors. Lancet 2003: 362 (9380): 271-80.Ezzati M., Lopez A.D., Rodgers A. et al. Selected major risk factors arid global and regional harden of disease. Lancet 2002: 360 (9343): 1347-60.Ezzati M., Lopez A.D., Rodgers A. et al. Selected major risk factors arid global and regional harden of disease. Lancet 2002: 360 (9343): 1347-60.Rywik S.L., Davis C.E., Pajak A. et al. Poland and US. collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment, and control of hypertension in the Pol-MONKA Project and the US. Atherosclerosis Risk in Communities Study: Ann Epidemiol 1998: 8 (1): 3-13.Rywik S.L., Davis C.E., Pajak A. et al. Poland and US. collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment, and control of hypertension in the Pol-MONKA Project and the US. Atherosclerosis Risk in Communities Study: Ann Epidemiol 1998: 8 (1): 3-13.
The authors declare that there are no conflicts of interest present.